Hydroxytyrosol Induces Dyslipidemia in an ApoB100 Humanized Mouse Model

Mol Nutr Food Res. 2024 Jan;68(1):e2300508. doi: 10.1002/mnfr.202300508. Epub 2023 Nov 7.

Abstract

Scope: Extra virgin olive oil has numerous cardiopreventive effects, largely due to its high content of (poly)phenols such as hydroxytyrosol (HT). However, some animal studies suggest that its excessive consumption may alter systemic lipoprotein metabolism. Because human lipoprotein metabolism differs from that of rodents, this study examines the effects of HT in a humanized mouse model that approximates human lipoprotein metabolism.

Methods and results: Mice are treated as follows: control diet or diet enriched with HT. Serum lipids and lipoproteins are determined after 4 and 8 weeks. We also analyzed the regulation of various genes and miRNA by HT, using microarrays and bioinformatic analysis. An increase in body weight is found after supplementation with HT, although food intake was similar in both groups. In addition, HT induced the accumulation of triacylglycerols but not cholesterol in different tissues. Systemic dyslipidemia after HT supplementation and impaired glucose metabolism are observed. Finally, HT modulates the expression of genes related to lipid metabolism, such as Pltp or Lpl.

Conclusion: HT supplementation induces systemic dyslipidemia and impaired glucose metabolism in humanized mice. Although the numerous health-promoting effects of HT far outweigh these potential adverse effects, further carefully conducted studies are needed.

Keywords: ApoB100; hydroxytyrosol; lipid metabolism; miRNAs; triglycerides.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Dyslipidemias* / etiology
  • Glucose
  • Humans
  • Lipoproteins
  • Mice
  • Olive Oil / pharmacology
  • Phenylethyl Alcohol* / pharmacology

Substances

  • 3,4-dihydroxyphenylethanol
  • Olive Oil
  • Phenylethyl Alcohol
  • Lipoproteins
  • Glucose